Table 2.

- Summary of Peterson’s study results versus the current empirical evidence.

	Peterson's study results (percentage of participants' preference of antidepressant treatment)	Evidence (APA Guidelines 2000, revised)
Efficacy	SSRIs (48%)	No difference
Sexual dysfunction	Fluoxetine (56%)	More common with paroxetine
Agitation	Fluoxetine (52%)	Comparable to other SSRIs
Discontinuation syndrome	Paroxetine (47%)	Occurs among short half-life antidepressants
Atypical depression	SSRIs (57%)	MAOIs
Melancholic depression	SSRIs (57%)	No specific recommendation, (pharmacotherapy and ECT leads to good responses)

APA - American Psychiatric Association, ECT - electric shock treatment, MAOIs - Monaoamine Oxidase Inhibitors, SSRIs - Selective Serotonin Reuptake Inhibitors